Unknown

Dataset Information

0

Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases.


ABSTRACT:

Background

In the urgent campaign to develop therapeutics against SARS-CoV-2, natural products have been an important source of new lead compounds.

Results

We herein identified two natural products, ginkgolic acid and anacardic acid, as inhibitors using a high-throughput screen targeting the SARS-CoV-2 papain-like protease (PLpro). Moreover, our study demonstrated that the two hit compounds are dual inhibitors targeting the SARS-CoV-2 3-chymotrypsin-like protease (3CLpro) in addition to PLpro. A mechanism of action study using enzyme kinetics further characterized the two compounds as irreversible inhibitors against both 3CLpro and PLpro. Significantly, both identified compounds inhibit SARS-CoV-2 replication in vitro at nontoxic concentrations.

Conclusions

Our finding provides two novel natural products as promising SARS-CoV-2 antivirals.

SUBMITTER: Chen Z 

PROVIDER: S-EPMC7914117 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7127169 | biostudies-literature
| S-EPMC4113264 | biostudies-literature
| S-EPMC7248907 | biostudies-literature
| S-EPMC7448953 | biostudies-literature
| S-EPMC8014511 | biostudies-literature
| S-EPMC9349924 | biostudies-literature
| S-EPMC8227062 | biostudies-literature
| S-EPMC7070521 | biostudies-literature
| S-EPMC10364469 | biostudies-literature
| S-EPMC7667826 | biostudies-literature